SCHEMBL25835553

SCHEMBL25835553

CC(C)(C)OC(=O)NCc1cnc(-c2ccc(F)cc2)cc1-c1cc[nH]n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.44
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
HTR2C P28335 2/20 0.36
MCHR1 Q99705 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
SCN9A Q15858 2/20 0.35
AAK1 Q2M2I8 4/20 0.35
PDPK1 O15530 1/20 0.35
NPC1 O15118 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
AURKA O14965 1/20 0.34
ABL1 P00519 1/20 0.34
NTRK1 P04629 1/20 0.34
LCK P06239 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34
MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25835682 0.88 ALOX5AP (0.40) GRM2ALOX5APFEN1L3MBTL1AAK1
SCHEMBL25835681 0.88 GRM2 (0.45) GRM2L3MBTL1SCN9AABL1ROCK1
SCHEMBL30510038 0.85 GRM2 (0.43) GRM2ALOX5APFEN1HTR2CMCHR1
SCHEMBL25836843 0.85 GRM2 (0.43) GRM2ALOX5APFEN1HTR2CMCHR1
SCHEMBL26193310 0.84 GRM2 (0.42) GRM2ALOX5APFEN1HTR2CMCHR1
SCHEMBL30509985 0.83 NTRK1 (0.46) GRM2ALOX5APFEN1HTR2CMCHR1
SCHEMBL25837946 0.83 NTRK1 (0.46) GRM2ALOX5APFEN1HTR2CMCHR1
SCHEMBL30510026 0.82 AAK1 (0.46) GRM2ALOX5APFEN1HTR2CMCHR1
SCHEMBL25835971 0.82 AAK1 (0.46) GRM2ALOX5APFEN1HTR2CMCHR1
SCHEMBL25257470 0.81 GRM2 (0.44) GRM2ALOX5APFEN1HTR2CMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
WO-2023122780-A9 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed
WO-2023122780-A2 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 GRM2 4239/4885ALOX5AP 3911/4885FEN1 1429/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 GRM2 4239/4885ALOX5AP 3911/4885FEN1 1429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.